Acquisitions - Acquired Intangible Assets (Details) - USD ($) $ in Thousands |
6 Months Ended | |
---|---|---|
May 04, 2018 |
Jun. 30, 2018 |
|
Gemini Laboratories, LLC Acquisition | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Preliminary Fair Values | $ 116,240 | |
Gemini Laboratories, LLC Acquisition | Licenses | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Preliminary Fair Values | $ 110,350 | |
Weighted Average Useful Life | 10 years | |
Gemini Laboratories, LLC Acquisition | Product rights for developed technologies | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Preliminary Fair Values | $ 5,500 | |
Weighted Average Useful Life | 9 years | |
Gemini Laboratories, LLC Acquisition | Product rights for out-licensed generics royalty agreement | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Preliminary Fair Values | $ 390 | |
Weighted Average Useful Life | 2 years | |
Impax Acquisition | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Preliminary Fair Values | $ 1,063,040 | |
Weighted Average Useful Life | 12 years 10 months 24 days |